Consequently, cisplatin-induced senescence (CIS) in βTrCP1-overexpressing cells leads to a gradual reduction of p21 CIP1, enabling cell cycle progression and increasing DNA damage, which ultimately results in cell death. This evidence concerns the gene BTRC and in situ carcinoma.